Brittney Turner, APRN
Nurse Practitioner · Las Vegas, NVNPI 1760061238
Payments from drug & device makers
Across 91 payments — averaging $23.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$381
- Hologic Sales And Service, LLC$380
- Astellas Pharma US Inc$301
- Mayne Pharma Commercial LLC$139
- Daiichi Sankyo Inc.$138
- Scynexis, Inc.$135
- plus $638 from 18 others
What the payments were for
- Food & beverage$2,112100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 20 | $381 |
| Hologic Sales And Service, LLC | 7 | $380 |
| Astellas Pharma US Inc | 8 | $301 |
| Mayne Pharma Commercial LLC | 6 | $139 |
| Daiichi Sankyo Inc. | 8 | $138 |
| Scynexis, Inc. | 14 | $135 |
| AstraZeneca(2 entities) | 2 | $121 |
| Shield Therapeutics Inc | 4 | $83 |
| Exeltis, USA Inc. | 4 | $76 |
| Optumhealth Care Solutions, LLC | 2 | $68 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $47 |
| Bayer | 2 | $43 |
| Kyowa Kirin, Inc. | 1 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Sanofi Pasteur Inc. | 1 | $18 |
| Pfizer | 1 | $18 |
| Myovant Sciences Inc. | 1 | $17 |
| Mycovia Pharmaceuticals, Inc. | 1 | $16 |
| Sumitomo Pharma America, Inc. | 1 | $16 |
| Agile Therapeutics, Inc. | 1 | $16 |
| Sunovion Pharmaceuticals Inc. | 1 | $15 |
| Millicent US Inc | 1 | $14 |
| Sage Therapeutics, LLC | 1 | $14 |
| GSK | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,112 in reported general payments places this provider in the 80th percentile of 933 nurse practitioner providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Propafenone Hcl ErPropafenone Hcl | 14 | $2,052 |
| Estradiol | 26 | $1,183 |
| Metronidazole | 14 | $484 |
| Allopurinol | 13 | $102 |
| Alendronate Sodium | 21 | $99 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Las Vegas
- Vanessa AntolinLas Vegas$225K
- Shannon SouthwickLas Vegas$85K
- Melanie SpeedLas Vegas$80K
- Shelley MilesLas Vegas$34K
- Nasslynne LenzLas Vegas$32K
- Bonnie KwanLas Vegas$30K
- Amanda RalphLas Vegas$26K
- Teodoro AgtayLas Vegas$25K
- Katherine WhitmireLas Vegas$18K
- Jennifer WalshLas Vegas$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.